We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 July 2024, highlighting Roche's ophthalmology franchise and pipeline, key ophthalmology data presented at the American Society of Retina Specialists Annual Meeting, and real world data of on-market products. 16:30 – 17:45 CEST / 15:30 – 16:45 BST 10:30 – 11:45 am EDT / 07:30 – 08:45 am PDT The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:30 CEST on the day of the event. >click here Agenda Welcome Bruno Eschli, Head of Investor Relations Ophthalmology franchise update Nilesh Mehta, Global Franchise Head of Ophthalmology Ophthalmology pipeline (early and late) Christopher Brittain, Senior Vice President and Global Head of Ophthalmology Product Development Key data presented at ASRS Arshad M. Khanani MD, MA, FASRS, Retina Specialist and Clinical Investigator Q&A Access to virtual event (pre-registration required) Please pre-register for our webinar here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webinar will be available via > ir.roche.com *privacy notice Best regards, | ||
Bruno Eschli Head of Investor Relations | Loren Kalm Head of Investor Relations, North America |
Roche Investor Relations | |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.